This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 October 2022 and includes updates on COVID-19, monkeypox, diphtheria, West Nile virus, measles, Ebola virus disease, cholera, influenza A(H5N6), poliomyelitis, seasonal influenza, and Avian influenza A(H5N1) in mink.
Version 6.1 is the final protocol for the third EU-wide point prevalence survey in acute care hospitals (PPS 2022–2023). It contains important changes compared to protocol version 5.3 (PPS 2016–2017), including on healthcare-associated COVID-19.
As of 26 September 2022, 92 cases of diphtheria among migrants, including a fatal one, have been reported this year by seven European countries – Austria, Germany, United Kingdom, Norway, Belgium, France and Switzerland.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 August 2022 and includes updates on monkeypox, West Nile virus, COVID-19, Ebola, Vibrio growth, diphtheria, cholera, chikungunya virus disease and dengue.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 July-6 August and includes updates on West Nile virus infection, monkeypox, COVID-19, cholera, diphteria, anthrax, Vibrio growth, Marburg virus disease, mass gatherings at the Birmingham 2022 Commonwealth games, MERS-CoV, and Poliovirus.
This report presents the results of the ECDC European Reference Laboratory Network for Pertussis (ERLNPert-Net) external quality assessment (EQA) scheme for Bordetella pertussis PCR, funded by ECDC on behalf of ERLNPert-Net and conducted from April to September 2020. The EQA was organised by the National Institute for Biological Standards and Control (NIBSC), based in Potter’s Bar, United Kingdom (UK).